feed,title,long_url,short_url
SeekingAlpha,Exelixis reports early-stage study results from cabozantinib/atezolizumab combo in solid tumors,https://seekingalpha.com/news/3615758,
SeekingAlpha,Albertsons Companies: Lots Of Concerns Despite An Earnings Boom,https://seekingalpha.com/article/4375506,
SeekingAlpha,General Electric: Ebullience Over Cash Flow Prospects Could Be Ethereal,https://seekingalpha.com/article/4375505,
SeekingAlpha,Cassava Sciences' Sumifilam: The Limits To Biomarker Studies In Alzheimer's Disease,https://seekingalpha.com/article/4375504,
